🏉 Cohort 1 Applications Open — Limited seats available for our inaugural Medtech Incubation Program.

Apply Before August 31 →
Investor & Partner Relations

A rare window into
Tier-2 India's
healthcare future.

800 million people. Severely underserved healthcare. A university-backed incubator with grant approvals, clinical infrastructure, and a founding team ready to build. This is the ground floor.

“An entrepreneur is someone who jumps off a cliff and builds a plane on the way down.”
— Reid Hoffman
Grant Approved — Blockchain for Impact (BFI)
Hosted by Bareilly International University
The Opportunity

The largest gap in
Indian healthcare.

India's ₹9 lakh crore healthcare market is concentrated in 8 metros. The Tier-2 and Tier-3 belt — where the majority of India actually lives — has virtually no medtech innovation infrastructure. BMIIL is built to close that gap, starting from Bareilly.

$372B

India Healthcare Market by 2030

Growing at 22% CAGR — driven largely by Tier-2 and rural demand.

800M+

People in Underserved Markets

Outside India's top-8 cities with limited access to modern medtech solutions.

<5%

Medtech Startups from Tier-2

Despite this market representing the majority of India's healthcare burden.

Lower Burn vs Metro Incubators

Bareilly's cost structure gives startups more runway for the same investment.

Why now is the moment
to back Tier-2 medtech.

01

Government tailwinds. PLI for medtech, Ayushman Bharat, National Digital Health Mission — all driving capital and attention toward underserved healthcare markets.

02

University infrastructure, de-risked. BIU's hospital, labs, and faculty are already in place. We're not building from scratch — we're activating what exists.

03

Ayurveda as a global differentiator. The ₹1.2 lakh crore global herbal and nutraceutical market has no credible scientifically-validated Indian pipeline. BMIIL's Ayush track is built to supply one.

04

First-mover in a white space. No comparable medtech incubator exists in Uttar Pradesh, India's most populous state. The addressable market is uncrowded and large.

Participation Models

How you can partner
with BMIIL.

We work with investors, corporates, hospitals, and institutions. Each engagement is structured to deliver clear value on both sides.

Financial Partner
Angel &
VC Investment

Direct equity participation in BMIIL's fund structure or co-investment rights into individual portfolio startups at pre-negotiated terms.

  • Preferred co-investment access
  • Quarterly portfolio updates
  • Demo day priority seating
  • Advisory board participation
  • Deal flow from BIU research pipeline
Best for: Angel networks, family offices, early-stage VC funds
Strategic Partner
Corporate &
Hospital Partner

Gain privileged access to BMIIL's innovation pipeline — with rights to pilot, license, or acquire technologies developed within the incubator.

  • First-look licensing rights
  • Dedicated problem statement pipeline
  • Named co-innovation track
  • Joint IP development options
  • Clinical trial facilitation
  • Co-branded research publications
Best for: Hospital chains, pharma cos., medical device companies
Institutional Partner
Grant &
Institutional

For government bodies, foundations, and development finance institutions seeking measurable impact in India's Tier-2 healthcare ecosystem.

  • Impact reporting & dashboards
  • Named program sponsorship
  • Research co-authorship
  • National replication framework
  • Policy engagement support
Best for: DST, BIRAC, foundations, development banks
Validation & Credibility

Already backed
by institutions
that matter.

We've secured grant approvals and letters of intent from [X] bodies before our first cohort launches — a rare signal of institutional confidence at this stage.

Blockchain For Impact (BFI) — ₹50 Lakh

Received from BFI for infrastructure setup and operations. BFI supports incubation centers in medical colleges to enhance India’s health capabilities. MOU signed October 2025, funds received November 2025.

Approved

“If it takes more than a sentence to explain what you are doing, it’s almost always a sign that what you are doing is too complicated.”

S
Sam Altman
CEO, OpenAI

Supported & recognised by

Startup India
BIU
[Grant Body]
[Partner]
Roadmap

Where we are.
Where we're going.

A transparent look at our journey — from approval to first cohort to national scale.

Phase 01 — Complete
Foundation & Approvals

Entity formation, BIU hosting agreement, grant applications submitted and first approvals received.

Phase 02 — In Progress
Infrastructure & Team

Lab setup, mentor network onboarding, regulatory advisors engaged. Investor & partner outreach active.

Phase 03 — Q[X] 2026
Cohort 1 Launch

First intake of 8–12 startups across Medtech Incubation and Ayush tracks. Demo Day at end of cohort.

Phase 04 — 2027
Scale & Replicate

Second cohort, accelerator program launch, inter-state replication framework with partner universities.

Get Involved

Three ways to
take the next step.

Whether you want to review the numbers, talk to the team, or formally register interest — here's where to start.

📄
Download Investor Deck

Our full pitch deck covers the opportunity thesis, financial model, partnership structures, team credentials, and grant pipeline.

PDF · ~18 slides · Updated [Month Year]
Download Deck
✉️
Expression of Interest

Formally register your interest. Our team will follow up within 48 hours with a tailored information pack and a calendar invite.

Response within 48 hrs · No commitment required
Submit EOI
Expression of Interest

Tell us
about your
interest.

We're building a small, high-quality group of founding partners and investors. Fill in the form and we'll be in touch within 48 hours.

48-Hour Response

Every submission is reviewed personally by the founding team. No auto-responders.

🔒

Confidential & No Obligation

Your information is never shared. Submitting an EOI does not constitute any commitment.

📦

Tailored Information Pack

We'll send you materials relevant to your specific type of partnership interest.

Register Your Interest

Takes less than 2 minutes. We'll take it from there.

🔒 Your information is kept strictly confidential and never shared with third parties.

Thank you.

We've received your expression of interest and will be in touch within 48 hours with a tailored information pack.

In the meantime, feel free to explore our programs or download our investor deck.